Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth.
Click here to learn more ›
Episodic Efficacy With Subcutaneous Bremelanotide Self-administered at Home by Premenopausal Women With Female Sexual Dysfunction (FSD) as Measured by the Female Sexual Encounter Profile- Revised
